Grundläggande statistik
| Insiderprofil | Adage Capital Management, L.P. |
| Portföljvärde | $ 1 940 717 021 |
| Aktuella positioner | 58 |
| Aktivistpositioner | 39 |
Senaste innehav, resultat, förvaltat kapital (från 13F, 13D)
13D/G-arkiveringar
Detta är en lista över 13D- och 13G-arkiveringar som gjorts under det senaste året (om några). Klicka på länken för att se hela transaktionshistoriken. Gröna rader indikerar nya positioner. Röda rader indikerar stängda positioner.
| Fil Datum | Formulär | Värdepapper | Föregående aktier |
Aktuella aktier |
ΔAktier % | % Ägande |
% ΔÄgande | |
|---|---|---|---|---|---|---|---|---|
| 2025-09-02 | PRAX / Praxis Precision Medicines, Inc. | 1 974 585 | 2 374 085 | 20,23 | 11,28 | 16,41 | ||
| 2025-08-12 | JANX / Janux Therapeutics, Inc. | 3 061 750 | 2 525 000 | −17,53 | 4,27 | −19,59 | ||
| 2025-08-12 | CDTX / Cidara Therapeutics, Inc. | 990 000 | 1 100 000 | 11,11 | 4,97 | −45,02 | ||
| 2025-08-12 | FULC / Fulcrum Therapeutics, Inc. | 3 000 000 | 4 589 000 | 52,97 | 8,50 | 52,88 | ||
| 2025-08-12 | IMUX / Immunic, Inc. | 1 398 600 | 10 479 337 | 649,27 | 9,99 | 544,52 | ||
| 2025-08-12 | ZEO / Zeo Energy Corp. | 760 000 | 760 000 | 0,00 | 3,22 | −45,88 | ||
| 2025-08-12 | INZY / Inozyme Pharma, Inc. | 0 | 0,00 | |||||
| 2025-08-12 | CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) | 6 954 000 | 8 403 000 | 20,84 | 6,29 | 20,50 | ||
| 2025-08-12 | WVE / Wave Life Sciences Ltd. | 12 516 500 | 15 016 500 | 19,97 | 9,65 | 18,40 | ||
| 2025-08-12 | SLNO / Soleno Therapeutics, Inc. | 4 392 696 | 3 575 964 | −18,59 | 7,10 | −25,89 | ||
| 2025-08-12 | CABA / Cabaletta Bio, Inc. | 3 634 475 | 9 002 580 | 147,70 | 9,99 | 34,45 | ||
| 2025-08-12 | ENSC / Ensysce Biosciences, Inc. | 74 711 | 74 711 | 0,00 | 3,15 | −40,79 | ||
| 2025-08-12 | PRQR / ProQR Therapeutics N.V. | 8 102 098 | 6 601 938 | −18,52 | 6,27 | −18,57 | ||
| 2025-08-12 | DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) | 14 614 449 | 9,99 | |||||
| 2025-08-12 | EYPT / EyePoint Pharmaceuticals, Inc. | 5 750 000 | 6 800 000 | 18,26 | 9,88 | 17,34 | ||
| 2025-08-12 | TCRX / TScan Therapeutics, Inc. | 1 350 000 | 2,52 | |||||
| 2025-08-12 | AMLX / Amylyx Pharmaceuticals, Inc. | 5 697 605 | 8 800 000 | 54,45 | 9,87 | 53,50 | ||
| 2025-08-12 | ALGS / Aligos Therapeutics, Inc. | 325 000 | 210 000 | −35,38 | 3,90 | −58,42 | ||
| 2025-08-12 | SDRL / Seadrill Limited | 4 200 535 | 3 138 286 | −25,29 | 5,04 | −25,44 | ||
| 2025-08-12 | ADGM / Adagio Medical Holdings, Inc. | 821 261 | 5,34 | |||||
| 2025-08-12 | TNGX / Tango Therapeutics, Inc. | 5 905 349 | 5,45 | |||||
| 2025-06-20 | / (38000Q201) | 50 912 | 0,37 | |||||
| 2025-05-12 | SLDB / Solid Biosciences Inc. | 1 754 159 | 6 729 484 | 283,63 | 8,68 | 90,77 | ||
| 2025-05-12 | TRAW / Traws Pharma, Inc. | 330 000 | 6,50 | |||||
| 2025-05-12 | ACRS / Aclaris Therapeutics, Inc. | 9 627 304 | 8 201 344 | −14,81 | 7,60 | −15,56 | ||
| 2025-05-12 | AEVA / Aeva Technologies, Inc. | 1 401 454 | 2,56 | |||||
| 2025-05-12 | URGN / UroGen Pharma Ltd. | 2 928 086 | 1 277 000 | −56,39 | 2,77 | −60,09 | ||
| 2025-05-12 | MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock) | 8 503 780 | 1,07 | |||||
| 2025-05-12 | TARA / Protara Therapeutics, Inc. | 2 250 000 | 0 | −100,00 | 0,00 | −100,00 | ||
| 2025-05-12 | LXEO / Lexeo Therapeutics, Inc. | 2 209 615 | 237 953 | −89,23 | 0,70 | −89,52 | ||
| 2025-05-12 | ABEO / Abeona Therapeutics Inc. | 4 210 429 | 4 411 572 | 4,78 | 8,78 | −12,11 | ||
| 2025-02-12 | STR / Sitio Royalties Corp. | 6 263 396 | 7,90 | |||||
| 2025-02-12 | ZVRA / Zevra Therapeutics, Inc. | 3 650 000 | 6,84 | |||||
| 2025-02-12 | KPTI / Karyopharm Therapeutics Inc. | 6 551 055 | 5,18 | |||||
| 2025-02-12 | DYNX / Dynamix Corporation | 1 350 000 | 8,13 | |||||
| 2025-02-12 | MNPR / Monopar Therapeutics Inc. | 599 195 | 9,86 | |||||
| 2025-02-12 | ENGN / enGene Holdings Inc. | 2 329 768 | 1 528 768 | −34,38 | 3,00 | −43,07 | ||
| 2024-11-12 | KALV / KalVista Pharmaceuticals, Inc. | 1 419 792 | 3,29 | |||||
| 2024-11-12 | STRO / Sutro Biopharma, Inc. | 2 250 132 | 2,75 | |||||
| 2024-11-12 | NKTX / Nkarta, Inc. | 3 600 000 | 5,10 | |||||
| 2024-11-12 | AMAL / Amalgamated Financial Corp. | 716 262 | 2,34 | |||||
| 2024-11-12 | MGTX / MeiraGTx Holdings plc | 5 229 099 | 6,77 | |||||
| 2024-11-12 | VSTM / Verastem, Inc. | 0 | 0,00 | |||||
| 2024-11-12 | ANNX / Annexon, Inc. | 3 485 931 | 3,28 | |||||
| 2024-11-12 | AURA / Aura Biosciences, Inc. | 4 881 125 | 9,84 | |||||
| 2024-11-12 | VINP / Vinci Compass Investments Ltd. | 0 | 0,00 | |||||
| 2024-11-12 | RZLT / Rezolute, Inc. | 2 842 163 | 4,91 | |||||
| 2024-11-12 | PWP / Perella Weinberg Partners | 1 037 615 | 1,90 | |||||
| 2024-11-12 | GHLD / Guild Holdings Company | 597 110 | 2,84 | |||||
| 2024-11-12 | SVRA / Savara Inc. | 6 753 701 | 4,10 | |||||
| 2024-11-12 | CRBP / Corbus Pharmaceuticals Holdings, Inc. | 528 937 | 4,39 | |||||
| 2024-11-12 | HOWL / Werewolf Therapeutics, Inc. | 2 000 594 | 4,58 | |||||
| 2024-11-12 | MTEM / Molecular Templates, Inc. | 0 | 0,00 | |||||
| 2024-11-12 | VERU / Veru Inc. | 7 861 111 | 5,37 | |||||
| 2024-11-12 | HRTX / Heron Therapeutics, Inc. | 8 850 000 | 5,84 | |||||
| 2024-11-12 | TENX / Tenax Therapeutics, Inc. | 369 097 | 9,99 | |||||
| 2024-11-04 | GLYC / GlycoMimetics, Inc. | 5 091 231 | 7,90 | |||||
| 2024-10-22 | ORKA / Oruka Therapeutics, Inc. | 175 000 | 0,50 |
